These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12067927)

  • 1. Patients with acute coronary syndrome should start a statin while still in hospital.
    Isles CG
    Heart; 2002 Jul; 88(1):5-6. PubMed ID: 12067927
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of physician-managed lipid-lowering care in patients with coronary heart disease in two time periods (1994 and 1999).
    Smith DA; Harnick D; Kilaru R
    Am J Cardiol; 2001 Dec; 88(12):1417-9, A6. PubMed ID: 11741564
    [No Abstract]   [Full Text] [Related]  

  • 3. Time trend analysis and variations in prescribing lipid lowering drugs in general practice.
    Baxter C; Jones R; Corr L
    BMJ; 1998 Oct; 317(7166):1134-5. PubMed ID: 9784452
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Dyslipidemia in Elderly Patients With Coronary Heart Disease: There Are Miles to Go Before We Sleep.
    Toth PP
    J Am Coll Cardiol; 2015 Oct; 66(17):1873-5. PubMed ID: 26493658
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimizing the prescription of statins after an acute coronary syndrome: the influence of coronary angioplasty and total cholesterol levels.
    Ferrières J; Danchin N; Grenier O; Cantet C; Thomas D; Cambou JP
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):559-60. PubMed ID: 11916367
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease.
    Harnick DJ; Cohen JL; Schechter CB; Fuster V; Smith DA
    Am J Cardiol; 1998 Jun; 81(12):1416-20. PubMed ID: 9645890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias?
    Abuful A; Gidron Y; Henkin Y
    Clin Cardiol; 2005 Aug; 28(8):389-93. PubMed ID: 16144216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering therapies in the management of acute coronary syndromes.
    Mosca L; Biviano A;
    Curr Cardiol Rep; 2002 Jul; 4(4):320-6. PubMed ID: 12052271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease.
    Kawecka-Jaszcz K; Jankowski P; Pajak A
    Int J Cardiol; 2003 Sep; 91(1):15-23. PubMed ID: 12957725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy in the new millennium: is there room for improvement?
    Brown WV
    Clin Cardiol; 2001 Aug; 24(8 Suppl):III1-2. PubMed ID: 11501597
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of coronary angiography on use of lipid-lowering agents in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. For the WISE Investigators.
    Bittner V; Olson M; Kelsey SF; Rogers WJ; Bairey Merz CN; Armstrong K; Reis SE; Boyette A; Sopko G
    Am J Cardiol; 2000 May; 85(9):1083-8. PubMed ID: 10781756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing LDL-C lowering with statins.
    McKenney JM
    Am J Ther; 2004; 11(1):54-9. PubMed ID: 14704596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns.
    Ruof J; Klein G; März W; Wollschläger H; Neiss A; Wehling M
    Prev Med; 2002 Jul; 35(1):48-53. PubMed ID: 12079440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin trials and goals of cholesterol-lowering therapy.
    Grundy SM
    Circulation; 1998 Apr; 97(15):1436-9. PubMed ID: 9576422
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin: building on success.
    Gaw A
    Hosp Med; 2001 Jan; 62(1):29-32. PubMed ID: 11211458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators.
    Eisenberg MJ; Califf RM; Cohen EA; Adelman AG; Mark DB; Topol EJ
    Am J Cardiol; 1997 Apr; 79(7):867-72. PubMed ID: 9104896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for expanded clinical utility of statin drugs.
    Hegele RA
    Curr Atheroscler Rep; 2001 May; 3(3):189-90. PubMed ID: 11286639
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of lipid-lowering medications in outpatients with coronary heart disease in the Department of Veterans Affairs System.
    Rubins HB; Nelson DB; Noorbaloochi S; Nugent S
    Am J Cardiol; 2003 Nov; 92(10):1177-82. PubMed ID: 14609592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
    LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF
    Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.